Academic Radiology
Volume 15, Issue 1 , Pages 15-23 , January 2008

Diagnostic Value of Contrast-Enhanced Fluid-Attenuated Inversion-Recovery and Delayed Contrast-Enhanced Brain MRI in Multiple Sclerosis

  • Mohammad Hadi Bagheri, MD

      Affiliations

    • Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
    • ,
  • Arash Meshksar, MD

      Affiliations

    • Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
    • Corresponding Author InformationAddress correspondence to: A.M.
    • ,
  • Seyyed Ali Nabavizadeh, MD

      Affiliations

    • Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
    • ,
  • Afshin Borhani-Haghighi, MD

      Affiliations

    • Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.
    • ,
  • Nahid Ashjazadeh, MD

      Affiliations

    • Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.
    • ,
  • Alireza R. Nikseresht, MD

      Affiliations

    • Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.

Received 28 June 2007 ,Accepted 26 July 2007.

References 

  1. Gebarski SS, Gabrielsen TO, Gilman S, Knake JE, Latack JT, Aisen AM. The initial diagnosis of multiple sclerosis: Clinical impact of magnetic resonance imaging. Ann Neurol. 1985;17:469–474
  2. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of MS. Ann Neurol. 2001;50(1):121–127
  3. Miller DH, Filippi M, Fazekas F, et al. Role of MRI within diagnostic criteria for multiple sclerosis. Ann Neurol. 2004;56:273–278
  4. Silver NC, Good CD, Barker GJ, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis: Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain. 1997;120(pt 7):1149–1161
  5. Silver NC, Tofts PS, Symms MR, Barker GJ, Thompson AJ, Miller DH. Quantitative contrast-enhanced MRI to evaluate blood-brain barrier integrity in multiple sclerosis: A preliminary study. Multiple Sclerosis. 2001;7:75–82
  6. Filippi M, Yousry T, Rocca MA, Fesl G, Voltz R, Comi G. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis. Acta Neurol Scand. 1997;95(6):331–334
  7. Wolansky LJ, Bardini JA, Cook SD, Zimmer AE, Sheffet A, Lee HJ. Triple-dose versus single-dose gadoteridol in multiple sclerosis patients. J Neuroimaging. 1994;4(3):141–145
  8. He J, Grossman RI, Ge Y, Mannon LJ. Enhancing patterns in multiple sclerosis: Evolution and persistence. AJNR Am J Neuroradiol. 2001;22:664–669
  9. Goo HW, Choi CG. Post-contrast FLAIR imaging of the brain in children: Normal and abnormal intracranial enhancement. Pediatr Radiol. 2003;33(12):843–849
  10. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: Gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology. 1999;211:257–263
  11. Essig M, Knopp MV, Schoenberg SO, et al. Cerebral gliomas and metastases: Assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology. 1999;210:551–557
  12. Griffiths PD, Coley SC, Romanowski CA, Hodgson T, Wilkinson ID. Contrast-enhanced fluid–attenuated inversion recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol. 2003;24:719–723
  13. Mihara F, Gupta KL, Righi AM. Non-T1 weighted spin-echo MR imaging with contrast material: Experimental and preliminary clinical assessment. Radiat Med. 1994;12:209–212
  14. Jackson EF, Hayman LA. Meningeal enhancement on fast FLAIR images. Radiology. 2000;215(3):922–924
  15. Kanamalla US, Baker KB, Boyko OB. Gadolinium diffusion into subdural space: Visualization with FLAIR MR imaging. AJR Am J Roentgenol. 2001;176:1604–1605
  16. Hirota T, Ishihara K, Akazawa K, Kubota T, Yamada K, Nishimura T. Delayed post-contrast FLAIR image for depicting meningeal carcinomatosis (Case report). Br J Radiol. 2004;77:528–531
  17. Ercan N, Gultekin S, Celik H, Tali TE, Oner YA, Erbas G. Diagnostic value of contrast enhanced fluid inversion recovery MR imaging of intracranial metastases. AJNR Am J Neuroradiol. 2004;25:761–765
  18. Rumpel H, Chan LL. Serial FLAIR imaging after Gd-DTPA contrast, pitfalls in stroke trial MRI. Stroke. 2003;34:797–798
  19. Singh SK, Leeds NE, Ginsberg LE. MR imaging of leptomeningeal metastases: Comparison of three sequences. AJNR Am J Neuroradiol. 2002;23:817–821
  20. Zheng-rong Z, Tian-zhen S, Xing-rong C, Wei-jun P. Diagnostic value of contrast-enhanced fluid attenuated inversion recovery MRI for intracranial tumors in comparison with post contrast T1W spin-echo MRI. Chin Med J. 2006;467–473119-6
  21. Essig M, Schoenberg SO, Debus J, Van Kaich G. Disappearance of tumor contrast on contrast-enhanced FLAIR imaging of cerebral gliomas. Magn Reson Imaging. 2000;18:513–518
  22. Melhem ER, Bert RJ, Walker RE. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain. AJR Am J Roentgenol. 1998;171:803–807
  23. Pyhtinen J, Karttunen A, Tikkakoski T. Increasing benefit of MRI in multiple sclerosis. Acta Radiol. 2006;47:960–971
  24. Maravilla KR. Enhancing our understanding of multiple sclerosis: Tracking contrast-enhanced plaques with MR imaging. AJNR Am J Neuroradiol. 2001;22:601–603
  25. McFarland HF, Stone LA, Calabresi PA, Maloni H, Bash CN, Frank JA. MRI studies of multiple sclerosis: Implications for the natural history of the disease and for monitoring effectiveness in experimental therapies. Multiple Sclerosis. 1996;2:198–205
  26. Ge Y. Multiple sclerosis: The role of MR imaging. AJNR Am J Neuroradiol. 2006;27:1165–1176
  27. Brex PA, O’Riordan JI, Miszkiel KA, et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology. 1999;53:1184–1190
  28. Tan IL, van Schijndel RA, Pouwels PJ, Adèr HJ, Barkhof F. Serial isotropic three-dimensional fast FLAIR imaging: Using image registration and subtraction to reveal active multiple sclerosis lesions. AJR Am J Roentgenol. 2002;179(3):777–782
  29. Bakshi R, Ariyaratana S, Benedict RH, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol. 2001;58(5):742–748
  30. Uysal E, Erturk M, Yildirim H, Seleker F, Basak M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am J Roentgenol. 2007;188:697–702
  31. Woo JH, Henry LP, Krejza J, Melhem ER. Detection of simulated multiple sclerosis lesions on T2-weighted and FLAIR images of the brain: Observer performance. Radiology. 2006;241(1):206–212
  32. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996;60:526–530

PII: S1076-6332(07)00450-3

doi: 10.1016/j.acra.2007.07.022

Academic Radiology
Volume 15, Issue 1 , Pages 15-23 , January 2008

Article Tools

* Image Usage & Resolution